ITOS

iTeos Therapeutics
ITOS

Overview Fund Activity
Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

54 hedge funds and large institutions have $614M invested in iTeos Therapeutics in 2020 Q3 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+54
Holders Change %
–
% of All Funds
1.09%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
54
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$109M
2
BC
2
Boxer Capital
California
$107M
3
MAM
3
MPM Asset Management
Massachusetts
$91.4M
4
MB
4
MPM BioImpact
Massachusetts
$58.1M
5
AG
5
Artal Group
Luxembourg
$27M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Legal & General Group
51
Legal & General Group
United Kingdom
$29K +$29K +1,193 New
AIP
52
Ameritas Investment Partners
Nebraska
$22K +$22K +911 New
Citigroup
53
Citigroup
New York
$13K +$13K +513 New
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$11K +$11K +496 New
1 2
3